Sensus Healthcare Expects Record 4Q 2021 Sales and Continued Growth in 1Q 2022; Profiles New Product at the 2022 Winter Clinical Dermatology Conference
Expects profitability for the 2021 fourth quarter and full year Physician KOL presentation at the Winter Clinical to highlight the TransDermal Infusion System™ BOCA RATON, Fla., Jan. 05, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that […]
Sensus Healthcare Signs Exclusive U.S. Distribution Agreement with Mattioli Eng. Italia for its TransDermal Infusion System
Sensus to Bring FDA-cleared Non-invasive Drug-delivery System and Treatment Alternative to Needles to Dermatologists Beginning [Immediately/Date] BOCA RATON, Fla, Dec. 01, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the signing of an exclusive U.S. distribution agreement […]
Sensus Healthcare Reports Third Quarter 2021 Financial Results
Achieves profitability on revenues of $5.5 million, up sharply from $1.6 million a year ago Affirms expectations for continued growth in 4Q and full-year profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 04, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, […]
Sensus Healthcare to Host Third Quarter 2021 Financial Results and Business Update Conference Call on November 4, 2021
BOCA RATON, Fla, Oct. 20, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 4, 2021 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter […]
Sensus Healthcare to Participate in Fireside Chat Hosted by Maxim Group and M-Vest
Fireside Chat with CEO Joe Sardano and CFO Javier Rampolla will be held October 19, 2021 at 11:00 a.m. ET BOCA RATON, Fla, Oct. 15, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Joseph Sardano, Chairman […]
Chinese Health Authority Renews License for Sensus Healthcare’s SRT-100™ for Five More Years
Third Renewal for System to Treat Non-melanoma Skin Cancer and Keloids Across Greater China BOCA RATON, Fla., Oct. 12, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that the Chinese Health Authority has renewed Sensus’ license to […]
Sensus Healthcare Announces Presentations, Demonstrations and Exhibit Booth at the 2021 Fall Clinical Conference in Las Vegas
Premier gathering expected to host more than 1,200 physicians with 500 virtual participants is the first in-person dermatology medical conference in 18 months Multiple tailwinds combine to support Sensus’ expectations for strong sales in 2H 2021 BOCA RATON, Fla., Oct. 07, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly […]
Sensus Healthcare to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
Boca Raton, Fla., Sept. 08, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced that Joe Sardano, chairman and chief executive officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference to be held virtually from […]
Sensus Healthcare Reports Second Quarter 2021 Financial Results
Revenues of $5.4 million up 358% year-over-year, up 77% sequentially Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 05, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three […]
Sensus Healthcare to Host Second Quarter 2021 Financial Results and Business Update Conference Call on August 5, 2021
BOCA RATON, Fla, July 29, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 5, 2021 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter […]
